Lymphoma Primary Effusion clinical trials

Explore recruiting lymphoma primary effusion clinical trials.

Recruiting lymphoma primary effusion studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Lymphoma Primary Effusion trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase 1, open-label, multicenter, dose escalation study of SRG-1505 as monotherapy in subjects with mature b-cell malignancies

France, Poland, Romania, Italy, Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Lymphoma Primary Effusion trials by city

Lymphoma Primary Effusion in Toronto Lymphoma Primary Effusion in Vancouver Lymphoma Primary Effusion in Montreal Lymphoma Primary Effusion in Calgary Lymphoma Primary Effusion in Edmonton Lymphoma Primary Effusion in Ottawa Lymphoma Primary Effusion in Winnipeg Lymphoma Primary Effusion in Quebec City Lymphoma Primary Effusion in Hamilton Lymphoma Primary Effusion in Kitchener Lymphoma Primary Effusion in London Lymphoma Primary Effusion in Halifax Lymphoma Primary Effusion in New York Lymphoma Primary Effusion in Los Angeles Lymphoma Primary Effusion in Chicago Lymphoma Primary Effusion in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease